Senior Director, Drug Development Services β Cardiometabolic
Posted 2 days ago
Posted 2 days ago
This is a fully remote position, open to applicants in California, +1 more state.
β’ Spearhead the design of strategic solutions for Cardiometabolic drug development, delivering customized, asset-focused approaches for liver diseases.
β’ Take ownership of comprehensive protocol development, encompassing design, scientific evaluation, and review for Phase IβIV clinical trials.
β’ Provide guidance to senior client stakeholders on strategies for Cardiometabolic development and the interpretation of data.
β’ Lead the creation of proposals, formulate study strategies, and oversee bid defense initiatives.
β’ Cultivate and sustain relationships with Cardiometabolic key opinion leaders (KOLs), advisory boards, and regulatory bodies.
β’ Develop service offerings centered around Cardiometabolic solutions while fostering innovation and growth in the drug development of liver diseases.
β’ Offer training, mentorship, and thought leadership to both internal teams and external partners.
β’ Engage in portfolio reviews, governance discussions, and provide scientific oversight.
β’ Assist operational teams through high-level scientific insights, investigator meetings, and study discussions.
β’ Represent ICON at Cardiometabolic congresses and scientific gatherings.
β’ Extensive and recognized expertise in the drug development of Cardiometabolic and liver diseases.
β’ Strong comprehension of Cardiometabolic clinical trial design, biomarkers, endpoints, fibrosis staging, histological and non-invasive markers, and the evolving therapeutic landscape.
β’ Demonstrated ability to function in a strategic, client-facing, consultative capacity within pharmaceutical or clinical research environments.
β’ Proven experience in engaging and influencing senior scientific and clinical stakeholders in both industry and academia.
β’ Exceptional communication and presentation skills, capable of converting complex Cardiometabolic data into actionable insights for development.
β’ Collaborative mindset with a global perspective and robust cross-functional leadership abilities.
β’ MD degree is required, preferably with a specialization or significant clinical/research experience in Cardiometabolic diseases.
β’ Must have the legal right to work in the country where the position is located.
β’ Competitive base salary along with performance-related incentives.
β’ Comprehensive medical, dental, and vision coverage where applicable.
β’ Access to retirement and pension plans.
β’ Life assurance and disability coverage.
β’ Employee assistance programs and resources for wellbeing.
β’ Opportunities for learning and development through structured training and career pathways.
β’ Potential for 20β40% domestic and international travel.
β’ A highly visible role focused on making a significant impact in shaping the future of Cardiometabolic drug development.
Connections Academy
Jazz Pharmaceuticals
Otsuka Pharmaceutical Companies (U.S.)
Get handpicked remote jobs straight to your inbox weekly.